Table 3.
Predicted stability and affinity change for clinically identified mutations in dapsone resistant M. leprae strains.
| Mutations in chain A of DHPS | mCSM (ΔΔG in kcal/mol) | Prime MM/GBSA* (ΔΔG in kcal/mol) | mCSM-ppi (ΔΔG in kcal/mol) | DynaMut (ΔΔG in kcal/mol) | Overall Impact | Reference |
|---|---|---|---|---|---|---|
| V39I | −0.61 | NA | −0.83 | 0.75 | Moderate Impact | [46] |
| V48G | −2.78 | NA | −0.75 | −10.00 | High Impact | [47] |
| V48A | −2.24 | NA | −0.86 | −6.02 | High Impact | [47] |
| V48L | −0.72 | NA | −1.23 | 0.44 | Moderate Impact | [47] |
| V48I | −0.72 | NA | −1.23 | 1.35 | Moderate Impact | [47] |
| V48F | −1.42 | NA | −0.87 | −1.26 | Moderate Impact | [47] |
| V48D | −2.71 | NA | −0.91 | −8.69 | Moderate Impact | [47] |
| T53A | −0.59 | −3.85 | −0.09 | 0.11 | High Impact | [47] |
| T53S | −0.40 | −2.69 | −0.24 | −1.09 | High Impact | [47] |
| T53V | −0.43 | −3.69 | −0.04 | 1.12 | High Impact | [48] |
| T53I | −0.40 | 0.20 | −0.01 | 2.58 | Moderate Impact | [47] |
| T53P | −0.43 | −1.30 | −0.04 | 1.05 | High Impact | [47] |
| T53N | −0.21 | −2.89 | −0.27 | 0.87 | High Impact | [47] |
| R54G | −0.52 | −9.12 | −0.66 | −0.11 | High Impact | [47] |
| R54W | −0.26 | −26.83 | −0.85 | −0.25 | High Impact | [47] |
| P55A | −0.48 | −2.78 | 0.03 | 0.14 | Moderate Impact | [47] |
| P55T | −0.44 | −1.17 | 0.38 | −0.14 | High Impact | [47] |
| P55S | −0.44 | −3.51 | 0.34 | 0.14 | Moderate Impact | [47] |
| P55L | −0.28 | −2.77 | 0.18 | 1.56 | Moderate Impact | [47] |
| P55H | −0.21 | −2.74 | 0.88 | 0.50 | Moderate Impact | [47] |
| P55R | 0.17 | −4.06 | 0.11 | −0.32 | Moderate Impact | [47] |
| T88P | −0.35 | NA | −0.20 | −1.84 | High Impact | [49] |
| D91H | 0.04 | NA | 0.79 | −0.01 | Moderate Impact | [49] |
| R94W | −0.21 | NA | −0.83 | 2.18 | Moderate Impact | [49] |
*NA = Not applicable. For Prime MM/GBSA, NA indicates that the residue is more than 5 Å from dapsone.